contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


opticept-forbattrar-sin-balansrakning-och-nar-lonsamhet-under-andra-halvaret-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Here are @lucas.mattsson’s comments on OptiCept’s capital raise preliminarily reaching 70 percent of their subscription target, which maintains the company’s cash flow at nearly the expected level.                   Inderes              OptiCept’s capital raise preliminary outcome at 70% of maximum gross proceeds...    OptiCept has announced the preliminary outcome of their rights issue, which indicates that subscriptions by exercise of subscription rights and subscription applications without subscription rights amount to a total of ~59% of the Rights Issue. Thus,...

@lucas.mattsson on tehnyt uuden analyysin OptiCeptistä.  The capital raise announced on Friday reduces the financing risks and secures the company’s financing until the end of 2025. Due to the overall structure of the raise, we expect it to succeed. With short-term financing in check, OptiCept can increase its focus on executing its growth strategy.                   Inderes              OptiCept Q3'24: Secures crucial funding for growth - Inderes    The capital raise announced on Friday reduces the financing risks and secures the company’s financing until the end of 2025. Due to the overall structure of the raise, we expect it to succeed. With short-term financing in check, OptiCept can increase...                             Rapsasta lainattua: We believe that OptiCept’s investment story relies on expectations related to long-term commercial success in both the FoodTech and PlantTech businesses. OptiCept has already developed a complementary product portfolio and secured its first large order, which improves the visibility of growth. On the other hand, receiving a few large orders does not guarantee that the company will continue to receive such orders regularly. In addition, the company’s historical performance provides little guidance as to future profitability and revenue growth. As a result, a wide range of potential outcomes

OptiCept has signed a rental agreement with the Central American company Mexifrutas for the rental of an OptiCept PEF system to enhance pineapple juice extraction. A successful evaluation period could lead to long-term cooperation and help expand OptiCept’s commercial operations in the fruit and juice industry. However, the project is in its early stages. Enhancing pineapple juice extraction means improving the process used to get more juice out of the pineapple. I didn’t know this before either.  Here are @lucas.mattsson’s comments on the matter:                   Inderes              OptiCept enters rental agreement for JuiceCept in Central America - Inderes    OptiCept has announced that it has signed a rental agreement with a customer in Central America for an OptiCept PEF system to increase pineapple juice extraction. If the evaluation during the rental period is successful and a potential long-term...

OptiCept on ilmoittanut, että sen asiakas La Salud on saanut taloudellista tukea EU:lta, mikä oli tärkeä edellytys aiemmin tiedotetun kahden OliveCept-järjestelmän tilauksen etenemiselle. Tässä olisi Lucaksen kommentit asiaan liittyen.  OptiCept has announced that its customer, La Salud, has received financial support from the European Union, which was a key condition to proceed with the previously communicated order for two OliveCept systems. This development is in line with our expectations and supports our estimates. Therefore, we are not making any adjustments to our estimates.                   Inderes              OptiCept secures previously communicated conditional order - Inderes    OptiCept has announced that its customer, La Salud, has received financial support from the European Union, which was a key condition to proceed with the previously communicated order for two OliveCept systems. This development is in line with our...

Here are Lucas’s comments regarding the options. OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so the outcome is roughly in line with our expectations, even though the exercise of the warrants was in our estimates for 2025. This will therefore have a minor impact on our estimates.                   Inderes              OptiCept’s outstanding warrants exercised - Inderes    OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so the outcome is...

Here are Lucas Mattsson’s comments on OptiCept signing a letter of intent (LOI) with Saab to explore a long-term partnership in Thailand aimed at improving productivity in the food and forestry industries. The cooperation could lead to new orders and a wider commercial scale in the FoodTech sector. However, the project is still in its early stages, and no details or schedules have yet been agreed upon.                   Inderes              OptiCept explores long-term partnership in Thailand - Inderes    OptiCept has announced that it has entered into a Memorandum of Understanding (MoU) with Saab, a key player within the defense industry. The Mou is intended to explore the possibility of forming a long-term partnership in Thailand focused on...

OptiCept Technologies develops and provides technological solutions specifically designed for the needs of the food and plant industries. The company’s technologies focus on improving the sustainability and utilization of raw materials, enabling more efficient production while reducing both waste and loss. OptiCept’s innovations relate to biological processes that, among other things, extend the shelf life of products, improve taste, color, and aroma, and preserve nutrients in the final product. Particularly through patented Pulsed (?) Electric Field (PEF) and Vacuum Infusion (VI) technologies, the company is able to offer unique solutions that help improve the efficiency and sustainability of production processes. OptiCept operates in international markets, and its headquarters are located in Lund, Sweden. At this point, I’ll say just to be sure:  I apologize for any potential misunderstandings; the company and the industry are difficult to understand even in Finnish, and I mainly read English-language material (or Swedish :D). Additionally, I had to use a lot of translation help. Any errors are very likely just my own misunderstandings.  An Investor’s Perspective: OptiCept Technologies is a growth company, as one might expect, focusing on innovative solutions in the food and plant sectors. The company utilizes two technology platforms: vacuum infusion in the PlantTech sector and pulsed electric fields in the FoodTech sector. Both technologies improve the handling and processing of raw materials, leading to longer shelf life, better quality, and reduced waste. The CEPT technology developed by the company is an advanced form of PEF technology that increases extraction efficiency and reduces the presence of microorganisms, such as bacteria and yeasts. This reduces the need for traditional heat treatment methods, such as pasteurization. OptiCept’s strategy is based on a broad “application area” of technology, covering, for example, olive oil, potatoes, juices, etc. The company’s equipment can process both solid and liquid foods, providing flexibility to reach new markets without additional development costs. For example, the OliveCept system integrates into existing production lines and optimizes productivity by improving extraction efficiency and product quality, bringing significant savings to producers. In terms of commercialization, OptiCept is in the early stages, which creates challenges for predictability and often requires additional funding, which naturally introduces a significant element of risk and unpredictability. On the other hand, the company has already secured significant customer contracts in both of its business areas and gained customers, including world-renowned companies, demonstrating the technology’s potential. The company’s business model is scalable, but its effectiveness is yet to be proven on a larger scale… OptiCept’s investment profile is high-risk, as mentioned above, but the company is thought to have the potential for high returns, as it operates in growing markets driven by sustainability trends. If the company can scale up its operations, the scalability will truly come into its own. The company’s technology offers cost-effective solutions that extend product shelf life and reduce waste, making it perhaps somewhat attractive from a sustainable development and eco-friendliness perspective. As a beginner-level investor, I still see this as a very uncertain case; if I were to dabble in these, I guess I would hold several “hit or miss” companies in small slices. the industry is challenging for me, and I believe that time and more evidence are required for investors to become interested in this company. Briefly about Q2 and the time following it: The company’s revenue grew by 117% in the second quarter but still fell short of forecasts. Due to high fixed costs, the operating result remained negative, and cash reserves were approximately 4.0 MSEK at the end of the period. However, the company later received a 10.3 MSEK loan, but at the current spending level, the company may need additional funding at the end of the year or early in 2025, although better cash flow from FPS orders would help. Short-term outlooks have been lowered, but long-term growth expectations remain unchanged regardless. According to Inderes’ estimate, the share value is 3.7–6.8 SEK (share price currently: 6.03 SEK on 29.8.2024 at 19:00), and considering the risks, it doesn’t seem that attractive at the moment. Copied from the company pages provided by Inderes:     To conclude, I want to say: forget my babbling and read the extensive report provided by Lucas from February, which has no paywalls and is thus readable by everyone. OptiCept Technologies provides solutions that enhance shelf life and quality in the food and plant industry. Through its innovative technology, which initially seems competitive, the company is actively addressing significant global sustainability challenges. However, the realization of broader commercial success, along with the timing of such a breakthrough, is dependable on future additional financing based on our estimates and involves considerable risk. Consequently, we anticipate a weak risk/return ratio over the next 12 months, despite our optimistic scenario supporting potential significant upside. https://www.inderes.fi/research/enable-economic-growth-climate-friendly-way  Then here is a brand new company report in Lucas’s style (30.08.2024 at 09:30): https://www.inderes.fi/research/opticept-q224-gearing-up-for-larger-deliveries

OptiCept Technologies

Som presenterats i helgen har OptiCept Technologies AB (publ) (“OptiCept”) ingått ett globalt kommersialiseringsavtal med FPS Food Process Solutions (“FPS”), en av världens ledande leverantö...

<div class="mfn-preamble">Som presenterats i helgen har OptiCept Technologies AB (publ) (“OptiCept”) ingått ett globalt kommersialiseringsavtal med FPS Food Process Solutions (“FPS”), en av världens ledande leverantörer av livsmedelsprocessutrustning. Samtidigt presenterades ett omfattande effektiviseringsprogram samt konvertering av lån till aktier.</div><div class="mfn-body">Avtalet med FPS tillsammans med att flerparten av bolagets långivare konverterar lånen till aktier ger en kraftigt stärkt balansräkningSom en del av den strategiska omställningen genomför OptiCept flera åtgärder för att stärka bolagets finansiella position.Konvertering av lån till aktierFlertalet långivare har begärt förtida konvertering av lån till aktier, vilket minskar bolagets skuldsättning avsevärt.LageröverlåtelseOptiCept överlåter lager till FPS-koncernen, vilket frigör kapital och minskar kapitalbindningen. Transaktionen bidrar även till att finansiera bolagets omställningskostnader i samband med den nya affärsmodellen.Sammantaget innebär dessa åtgärder att OptiCept sänker sina skulder avsevärt, samtidigt som bolaget, tillsammans med att övriga fordringar realiseras, är finansierat fram till positivt kassaflöde från den löpande verksamheten.Effektiviseringsprogram skapar väg till lönsamhetOptiCept genomför parallellt ett effektiviseringsprogram som reducerar bolagets kostnadsbas till cirka 25 MSEK på årsbasis.Programmet omfattar:<ul><li>organisatoriska anpassningar</li><li>personalreduktioner</li><li>minskade externa kostnader</li></ul>Tillsammans med de nya licensintäkterna skapar detta förutsättningar för att bolaget ska kunna nå positivt resultat under andra halvåret 2026.För ytterligare information, vänligen kontaktaOptiCept Technologies AB (publ) Ulf Hagman Styrelseordförande 0733636380 ulf.hagman@opticept.se</div><div class="mfn-footer mfn-contacts mfn-311c5cccce64">Kontakter<hr></div><div class="mfn-footer mfn-about mfn-e9a555d95d17">Om oss<hr>OptiCept Technologies AB (publ), 556844-3914 förser livsmedels-och växtindustrin med högteknologiska lösningar som bidrar till en mer hållbar värld och möjliggör klimatsmart ekonomisk tillväxt. OptiCept optimerar biologiska processer - Ökad extraktion ur råvaran, förlängd hållbarhet, minskat avfall och förbättrad kvalitet (smak, doft, färg, näringsinnehåll) hos slutprodukten. Teknologins positiva effekter ger såväl ekonomiska fördelar för kunden, bättre produkter för konsumenten och mindre påverkan på vår miljö.&nbsp; &nbsp; Genom patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion), öppnar vi upp nya affärsmöjligheter för livsmedels- och växtförökningsindustrin över hela världen. OptiCepts vision är att bidra till en mer hållbar värld genom banbrytande teknologi för livsmedels- och växtindustrin. &nbsp; Företaget finns i Lund och aktien handlas på Nasdaq First North Growth Market (kortnamn: OPTI). Bolagets Certified Adviser är Tapper Partners AB.För ytterligare information: <a href="http://www.opticept.se" rel="noopener">OptiCept Technologies officiell hemsida</a></div><div class="mfn-footer mfn-attachment mfn-attachment-general">Bifogade filer<hr><a class="mfn-generated mfn-primary" href="https://storage.mfn.se/73892865-2837-4eb0-ba10-8cf240fd8188/opticept-forbattrar-sin-balansrakning-och-nar-lonsamhet-under-andra-halvaret-2026.pdf" rel="noopener">OptiCept förbättrar sin balansräkning och når lönsamhet under andra halvåret 2026</a></div>